Visualizing cancer in a different light

Lexington, KY | October 25, 2021—NX Development Corp. exhibited at the 2021 Congress of Neurological Surgeons (CNS) Annual Meeting in Austin, TX. This meeting could be described as a complete success due to the high in-person attendance, numerous...

LEXINGTON, KY |GlobeNewswire| April 15, 2021 — NX Development Corp. (NXDC), a life-sciences company wholly owned by photonamic GmbH & Co. KG., today announced that Tracy Jerome “T.J.”  Stalvey has been named Vice President of Clinical Operations. 

Lexington, KY, Jan. 12, 2021 (GLOBE NEWSWIRE) — NX Development Corp. (NXDC), a life sciences company wholly owned by photonamic GmbH & Co. KG., today announced FDA orphan-drug designation for Gleolan, an optical imaging agent for the...

LEXINGTON, KY |GlobeNewswire| November 17, 2020 — NX Development Corp (NXDC), a life sciences company wholly owned by photonamic GmbH & Co. KG., today announced the enrollment of the first patient in a Phase III multicenter study of Gleolan to...

Dr. Christian Ramsey first neurosurgeon in state to use Gleolan™ for enhanced visualization of high-grade gliomas/glioblastoma

Lexington, KY | September 1, 2019 — NXDC was proud to be an exhibitor and supporter of the American Association of Neurological Surgeons Annual Scientific Meeting 2019 in San Diego, CA and we are already looking forward to AANS 2020 in...